Medovate and its Singapore-based distributor Bluestone Corporation Pte Ltd have announced they have secured Singapore’s Health Sciences Authority (HSA) approval for the game-changing SAFIRA® (SAFer Injection for Regional Anaesthesia) system. The regulatory approval means the UK based company – dedicated to the development and commercialisation of innovative medical technologies from within the NHS – can immediately... Read more »

The post Medovate secures HSA approval in Singapore for game-changing SAFIRA® system appeared first on Lifescience Industry News.